Catalyst Wire Dossier Catalyst Wire Dossier

Oral antidiabetic agent (Phase 2 trial)

· Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oral antidiabetic agent (Phase 2 trial), covering 2006-07-19 to 2006-07-19. Get the full timeline:

Most recent: Clinical Trial Update: An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes [Phase 2]

See pricing